...
首页> 外文期刊>FEBS letters. >Cloning and functional characterization of TCRP1, a novel gene mediating resistance to cisplatin in an oral squamous cell carcinoma cell line.
【24h】

Cloning and functional characterization of TCRP1, a novel gene mediating resistance to cisplatin in an oral squamous cell carcinoma cell line.

机译:TCRP1的克隆和功能表征,一种介导口腔鳞状细胞癌细胞系对顺铂耐药的新型基因。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

To explore the mechanisms of chemotherapy resistance, we previously established a multi-drug resistant cell line, Tca8113/Pingyangmycin (Tca8113/PYM) and identified differential expression in known genes and ESTs using microarray analysis. From among those ESTs we have now identified a novel gene producing an mRNA of 1834 nucleotides translated into a protein having 235 amino acids. This gene was denominated as tongue cancer resistance-associated protein 1 gene (TCRP1, accession number: EF363480). We further determined its functional characteristics. The results demonstrate that TCRP1 mediates a specific resistance to cisplatin in Tca8113 cells by reducing the cisplatin-induced apoptosis. This suggests that TCRP1 might be a novel molecular target to develop agents to reverse cisplatin-induced chemoresistance.
机译:为探索化学疗法抗性的机制,我们先前建立了多药耐药性细胞系Tca8113 /平阳霉素(Tca8113 / PYM),并使用微阵列分析鉴定了已知基因和EST中的差异表达。从这些EST中,我们现在已经鉴定出一种新基因,该基因产生1834个核苷酸的mRNA,翻译成具有235个氨基酸的蛋白质。该基因被命名为舌癌抗性相关蛋白1基因(TCRP1,登录号:EF363480)。我们进一步确定了其功能特征。结果表明,TCRP1通过减少顺铂诱导的细胞凋亡介导了Tca8113细胞对顺铂的特异性抗性。这表明TCRP1可能是开发逆转顺铂诱导的化学耐药性药物的新型分子靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号